Keyphrases
Next-generation Sequencing
100%
Robin
100%
Tumor Tissue
100%
High-grade Serous Ovarian Cancer (HGSOC)
100%
First International
100%
Ovarian Tissue
100%
Mutation Testing
100%
BRCA1, BRCA2
100%
Tumor
40%
Test Center
40%
Breast Cancer Susceptibility Gene 1 (BRCA1)
40%
BRCA2
40%
Olaparib
40%
Coding Region
20%
Molecular Diagnostics
20%
Austrian
20%
Monotherapy
20%
Sanger Sequencing
20%
Biopsy Specimen
20%
Sequence Method
20%
Central Europe
20%
Quality Management
20%
High Failure Rate
20%
Testing Method
20%
Diagnostic Test
20%
Clinical Decision-making
20%
Rapid Analysis
20%
Ovarian Cancer
20%
Surgical Resection
20%
Economic Analysis
20%
Tumor Samples
20%
Technological Improvement
20%
Resection Specimen
20%
Molecular Pathology
20%
Screening Approach
20%
Ovarian Cancer Patients
20%
Next-generation Sequencing Methods
20%
Platinum Sensitivity
20%
Druggability
20%
Oncogenic mutations
20%
Formalin-fixed
20%
Technological Quality
20%
Paraffin Embedding
20%
Mutational Hotspots
20%
Predictive Testing
20%
Surgical Biopsy
20%
Focused Screening
20%
Targeted Panel
20%
Number of Tests
20%
Medicine and Dentistry
Neoplasm
100%
Ovarian Cancer
100%
BRCA1
100%
Next Generation Sequencing
100%
BRCA2
25%
Olaparib
25%
Monotherapy
12%
Carcinogenesis
12%
Biopsy Technique
12%
Clinical Decision Making
12%
Molecular Pathology
12%
Sanger Sequencing
12%
Predictive Testing
12%
Molecular Diagnostics
12%
Diagnostic Testing
12%